Blockbuster drugs coming off patent: will cap contracts benefit?
Health care organizations and PBMs continue to struggle to find ways to contain prescription drug expenditures, but upcoming patent expirations on blockbuster drugs may help the bottom line.
D002204:Capitation Fee; D017046:Cost Savings / Q000379:methods; D011307:Drug Prescriptions / Q000191:economics*; D006279:Health Maintenance Organizations / Q000191:economics* / Q000458:organization & administration; D010330:Patents as Topic; D014481:United States